Friday 6 November 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024.

Revenue: +10.6%
EPS: −104.4%
Free cash flow: −69.3%
Total debt: +16.0%

Quarter to September 2026, against a year earlier

248.54 4.61 +1.89%

Follow BIIB

Alert me

Market cap: $36.1B
P/E: 104×
Fwd P/E: 47.4×
Dividend yield: —
F-score: 4/9
Altman Z: 3.13
Beneish M: −2.67
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

	Sep '26	Jun '26	Mar '26	Dec '25	Older periods
ROE Full definition →	1.87%	4.58%	7.70%	7.39%	+8 more TTM periods Free account
Piotroski F-Score Full definition →	3	3	4	4
ROA Full definition →	1.13%	2.76%	4.77%	4.50%
ROIC Full definition →	1.94%	3.11%	5.69%	5.61%
Return on Tangible Assets Full definition →	5.22%	13.08%	14.90%	14.89%
Average Days of Receivables Full definition →	66.80	68.63	50.29	49.54
Free Cash Flow per Share Full definition →	11.46	17.20	16.31	13.78
Free Cash Flow Full definition →	1,694.40	2,540.00	2,401.30	2,019.20
Capital Expenditures Full definition →	(552.70)	(338.80)	(189.50)	(185.40)
Other line items
Cash ROIC Full definition →	6.16%	9.26%	8.22%	7.12%
Accounts Receivable Turnover Full definition →	6.32	5.71	5.91	7.20
Accounts Payable Turnover Full definition →	6.36	6.42	6.50	5.62
Inventory Turnover Full definition →	1.21	1.12	1.15	1.04
Average Days of Payables Full definition →	58.57	56.53	53.72	65.59
Days of Inventory on Hand Full definition →	302.75	333.72	292.04	329.16
Tax Rate Full definition →	(0.22)	(0.17)	(0.15)	(0.17)
Research and Development Expense of Revenue Full definition →	20.90%	20.08%	18.95%	17.98%
Selling, General and Administrative Expense of Revenue Full definition →	26.72%	25.87%	24.84%	24.61%
Share Based Compensation of Revenue Full definition →	2.94%	2.95%	2.96%	2.94%
Operating CF/Net income Full definition →	6.47	3.45	1.89	1.71
Depreciation/Fixed assets Full definition →	0.51	0.45	0.38	0.35
Capex/Depreciation Full definition →	(0.36)	(0.25)	(0.16)	(0.17)
Revenue per Share Full definition →	69.67	67.89	67.51	67.51
Operating CF per Share Full definition →	15.20	19.49	17.60	15.05
Capex per Share Full definition →	(3.74)	(2.29)	(1.29)	(1.27)
Capex to Sales Full definition →	0.05	0.03	0.02	0.02

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026

Stockrow Weekly